{"id":"buclizine","rwe":[{"pmid":"41730890","year":"2026","title":"Direct synthesis of bicyclo[1.1.1]pentane (BCP) boronates from carboxylic acids.","finding":"","journal":"Nature communications","studyType":"Clinical Study"},{"pmid":"38632089","year":"2024","title":"Comparison of Classical and Green RPLC Methods in the Determination of pK(a) Values of Some Piperazine Group Antihistamines.","finding":"","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)","studyType":"Clinical Study"},{"pmid":"38313503","year":"2024","title":"Electrochemical HPLC Determination of Piperazine Antihistamine Drugs Employing a Spark-Generated Nickel Oxide Nanoparticle-Modified Carbon Fiber Microelectrode.","finding":"","journal":"ACS omega","studyType":"Clinical Study"},{"pmid":"37935935","year":"2024","title":"Understanding the Multi-Functional Role of TCTP in the Regeneration Process of Earthworm, Perionyx excavatus.","finding":"","journal":"Tissue engineering and regenerative medicine","studyType":"Clinical Study"},{"pmid":"35243250","year":"2022","title":"Understanding flow chemistry for the production of active pharmaceutical ingredients.","finding":"","journal":"iScience","studyType":"Clinical Study"}],"tags":[{"label":"buclizine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"R06AE01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Motion sickness","category":"indication"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:39:30.369188","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BUCLIZINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:57:37.546159+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Buclizine","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-19T23:57:45.483550+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:57:43.985700+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUCLIZINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:57:44.425525+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201271/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:57:45.129215+00:00"}},"allNames":"buclifen","offLabel":[],"synonyms":["buclizine","buclifen","histabuticine","histabutizine","histabutyzine","hitabutyzyne","buclizine hydrochloride","buclizine HCl"],"timeline":[],"brandName":"Buclifen","ecosystem":[{"indication":"Motion sickness","otherDrugs":[{"name":"cyclizine","slug":"cyclizine","company":"Glaxosmithkline"},{"name":"dimenhydrinate","slug":"dimenhydrinate","company":"Alra"},{"name":"meclozine","slug":"meclozine","company":"Citron Pharma Llc"},{"name":"scopolamine","slug":"scopolamine","company":"Novartis"}],"globalPrevalence":null}],"mechanism":{"target":"Histamine H1 receptor","novelty":"First-in-class","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor","isPrimary":true,"activityType":"","activityValue":null}],"modality":"Small Molecule","drugClass":"buclizine","explanation":"","oneSentence":"","technicalDetail":"Buclizine acts as a competitive antagonist at the histamine H1 receptor, inhibiting the central nervous system's response to histamine and thereby reducing the incidence of motion sickness symptoms."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Buclizine","title":"Buclizine","extract":"Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/416","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUCLIZINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Buclizine","fields":["history","overview"],"source":"Wikipedia"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T09:07:31.582570","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:57:46.776499+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cyclizine","drugSlug":"cyclizine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"chlorcyclizine","drugSlug":"chlorcyclizine","fdaApproval":"","relationship":"same-class"},{"drugName":"meclozine","drugSlug":"meclozine","fdaApproval":"1957-02-14","relationship":"same-class"},{"drugName":"cetirizine","drugSlug":"cetirizine","fdaApproval":"1995-12-08","patentExpiry":"Sep 15, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"levocetirizine","drugSlug":"levocetirizine","fdaApproval":"2007-05-25","patentExpiry":"Oct 16, 2027","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"buclizine","indications":{"approved":[{"name":"Motion sickness","source":"DrugCentral","snomedId":37031009,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_fixedFields":["primaryTarget"],"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"cyclizine","brandName":"cyclizine","genericName":"cyclizine","approvalYear":"","relationship":"same-class"},{"drugId":"chlorcyclizine","brandName":"chlorcyclizine","genericName":"chlorcyclizine","approvalYear":"","relationship":"same-class"},{"drugId":"meclozine","brandName":"meclozine","genericName":"meclozine","approvalYear":"1957","relationship":"same-class"},{"drugId":"cetirizine","brandName":"cetirizine","genericName":"cetirizine","approvalYear":"1995","relationship":"same-class"},{"drugId":"levocetirizine","brandName":"levocetirizine","genericName":"levocetirizine","approvalYear":"2007","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000147735","NDDF":"003404","UNII":"0C94V6X681","VUID":"4019642","CHEBI":"CHEBI:3205","VANDF":"4018463","INN_ID":"291","RXNORM":"59636","UMLSCUI":"C0164386","chemblId":"CHEMBL1201271","ChEMBL_ID":"CHEMBL1201271","KEGG_DRUG":"D02089","DRUGBANK_ID":"DB00354","PUBCHEM_CID":"6729","SNOMEDCT_US":"1956002","IUPHAR_LIGAND_ID":"7134","SECONDARY_CAS_RN":"129-74-8","MESH_SUPPLEMENTAL_RECORD_UI":"C046894"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Stuart Pharms","relationship":"FDA Licensee"}],"publicationCount":49,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R06AE01","allCodes":["R06AE01","R06AE51"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb 23","pmid":"41730890","title":"Direct synthesis of bicyclo[1.1.1]pentane (BCP) boronates from carboxylic acids.","journal":"Nature communications"},{"date":"2024 Jun 17","pmid":"38632089","title":"Comparison of Classical and Green RPLC Methods in the Determination of pK(a) Values of Some Piperazine Group Antihistamines.","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"date":"2024 Jan 30","pmid":"38313503","title":"Electrochemical HPLC Determination of Piperazine Antihistamine Drugs Employing a Spark-Generated Nickel Oxide Nanoparticle-Modified Carbon Fiber Microelectrode.","journal":"ACS omega"},{"date":"2024 Feb","pmid":"37935935","title":"Understanding the Multi-Functional Role of TCTP in the Regeneration Process of Earthworm, Perionyx excavatus.","journal":"Tissue engineering and regenerative medicine"},{"date":"2022 Mar 18","pmid":"35243250","title":"Understanding flow chemistry for the production of active pharmaceutical ingredients.","journal":"iScience"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1982","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:57:46.776499+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}